Literature DB >> 12054659

Different regulation of the LXRalpha promoter activity by isoforms of CCAAT/enhancer-binding proteins.

Knut R Steffensen1, Gertrud U Schuster, Paolo Parini, Elin Holter, Christine M Sadek, Tobias Cassel, Winnie Eskild, Jan-Ake Gustafsson.   

Abstract

LXRs have recently been shown to regulate key enzymes in cholesterol degradation, reverse transport of cholesterol from peripheral cells, cholesterol uptake and lipogenesis. The LXRalpha promoter was thus studied to investigate if LXRalpha gene expression is under the regulation of transcription factors involved in adipogenesis. We report that the C/EBP transcription factor interacts with the promoter of the LXRalpha gene. In in vitro footprinting experiments, protein extracts from several tissues gave footprints covering a putative C/EBP recognition site. Transfection experiments and EMSA showed a direct effect of these transcription factors on the LXRalpha promoter. C/EBPalpha upregulated expression of the reporter gene in an NIH 3T3-L1 preadipocyte cell line, while C/EBPbeta and C/EBPdelta had no effect. In liver hepatoma Fao II and Cos-7 kidney cells, both C/EBPalpha and C/EBPbeta downregulated expression of the reporter gene while C/EBPdelta induced activity, indicating that the functional consequences of C/EBP isoform interactions with the LXRalpha promoter are dependent on the cellular context. Monitoring of the LXR mRNA levels during adipose tissue differentiation showed that LXRbeta is constitutively expressed during the entire differentiation process while LXRalpha is induced upon addition of differentiation mix.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054659     DOI: 10.1016/S0006-291X(02)00390-X

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.

Authors:  Mirko Marabese; Faina Vikhanskaya; Cristina Rainelli; Toshiyuki Sakai; Massimo Broggini
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

2.  Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation.

Authors:  Amin Majdalawieh; Lei Zhang; Ilia V Fuki; Daniel J Rader; Hyo-Sung Ro
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

3.  Sesamol and sesame (Sesamum indicum) oil enhance macrophage cholesterol efflux via up-regulation of PPARγ1 and LXRα transcriptional activity in a MAPK-dependent manner.

Authors:  Amin F Majdalawieh; Hyo-Sung Ro
Journal:  Eur J Nutr       Date:  2014-08-01       Impact factor: 5.614

Review 4.  The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD.

Authors:  Emmanuel D Dixon; Alexander D Nardo; Thierry Claudel; Michael Trauner
Journal:  Genes (Basel)       Date:  2021-04-26       Impact factor: 4.096

Review 5.  Liver X receptors and fat cell metabolism.

Authors:  J Laurencikiene; M Rydén
Journal:  Int J Obes (Lond)       Date:  2012-02-28       Impact factor: 5.095

6.  Liver X receptor and STAT1 cooperate downstream of Gas6/Mer to induce anti-inflammatory arginase 2 expression in macrophages.

Authors:  Si-Yoon Kim; Eun-Jin Lim; Young-So Yoon; Young-Ho Ahn; Eun-Mi Park; Hee-Sun Kim; Jihee Lee Kang
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

7.  Induction of adipocyte differentiation by polybrominated diphenyl ethers (PBDEs) in 3T3-L1 cells.

Authors:  Emily W Y Tung; Adèle Boudreau; Michael G Wade; Ella Atlas
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

Review 8.  Mesenchymal Stem Cells and Metabolic Syndrome: Current Understanding and Potential Clinical Implications.

Authors:  Kenichi Matsushita
Journal:  Stem Cells Int       Date:  2016-05-29       Impact factor: 5.443

9.  Nuclear hormone receptor LXRα inhibits adipocyte differentiation of mesenchymal stem cells with Wnt/beta-catenin signaling.

Authors:  Kenichi Matsushita; Fulvio Morello; Zhiping Zhang; Tomoko Masuda; Shiro Iwanaga; Knut R Steffensen; Jan-Åke Gustafsson; Richard E Pratt; Victor J Dzau
Journal:  Lab Invest       Date:  2015-11-23       Impact factor: 5.662

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.